Scarica l'app Stockscreener
69.12
1.96%
-1.38
Dopo l'orario di chiusura:
69.00
-0.12
-0.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$70.50
Aprire:
$69.64
Volume 24 ore:
1.65M
Relative Volume:
0.88
Capitalizzazione di mercato:
$33.41B
Reddito:
$10.63B
Utile/perdita netta:
$819.00M
Rapporto P/E:
41.70
EPS:
1.6577
Flusso di cassa netto:
$1.59B
1 W Prestazione:
-3.67%
1M Prestazione:
-3.75%
6M Prestazione:
-15.01%
1 anno Prestazione:
-13.57%
Intervallo 1D:
$68.86
$69.64
Intervallo di 1 settimana:
$68.86
$73.52
Portata 52W:
$61.84
$87.64
Alcon Inc Stock (ALC) Company Profile
Nome
Alcon Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare ALC vs ISRG, BDX, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
69.12 | 34.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
350.16 | 129.55B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.10 | 50.32B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
221.05 | 32.94B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.69 | 32.10B | 29.14B | 1.07B | 1.05B | 1.1956 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-26 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | Iniziato | William Blair | Mkt Perform |
| 2026-01-20 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Downgrade | Stifel | Buy → Hold |
| 2025-12-11 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-08-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Reiterato | BTIG Research | Buy |
| 2025-03-28 | Reiterato | Needham | Buy |
| 2025-03-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-01-24 | Reiterato | Needham | Buy |
| 2025-01-10 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Reiterato | Needham | Buy |
| 2024-11-12 | Reiterato | Needham | Buy |
| 2024-10-10 | Aggiornamento | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Iniziato | Goldman | Buy |
| 2024-03-14 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Iniziato | Bernstein | Outperform |
| 2023-12-18 | Downgrade | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Aggiornamento | Societe Generale | Sell → Hold |
| 2022-12-22 | Iniziato | Mizuho | Buy |
| 2022-11-17 | Downgrade | Societe Generale | Hold → Sell |
| 2022-08-11 | Downgrade | Societe Generale | Buy → Hold |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-05-12 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-11 | Iniziato | BofA Securities | Buy |
| 2022-01-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Iniziato | Oppenheimer | Perform |
| 2021-07-14 | Iniziato | Deutsche Bank | Buy |
| 2021-05-06 | Aggiornamento | Citigroup | Sell → Neutral |
| 2021-03-22 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-11-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-07-06 | Downgrade | Citigroup | Neutral → Sell |
| 2020-07-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-04-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Argus | Hold → Buy |
| 2020-03-24 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-03-13 | Aggiornamento | UBS | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-26 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-01-08 | Iniziato | Argus | Hold |
| 2019-10-29 | Iniziato | Stephens | Equal-Weight |
| 2019-08-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-06-24 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-06-14 | Iniziato | BTIG Research | Neutral |
| 2019-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Alcon Inc Borsa (ALC) Ultime notizie
Alcon stock dips as investors weigh product news and upcoming Q3 2026 earnings - AD HOC NEWS
Alcon stock heads into the open after a modest September 7, 2026 decline - AD HOC NEWS
Alcon stock edges lower as investors weigh recent performance and upcoming Q3 earnings - AD HOC NEWS
Alcon Inc. (ALC) Stock Analysis: Exploring A Promising 20.91% Upside Potential - DirectorsTalk Interviews
Alcon stock heads into the open after a modest decline - AD HOC NEWS
Alcon Stock Price Forecast. Should You Buy ALC? - StockInvest.us
Alcon introduces UNITY M ophthalmic microscope - Glance by Eyes On Eyecare
Alcon stock trades softer as options activity and Q2 growth shape investor view - AD HOC NEWS
Alcon Market Sentiment - es.benzinga.com
Alcon stock eases after UNITY M launch and strong Q2 figures - AD HOC NEWS
The Back-to-School Essential Parents Are Overlooking: Eye Exams - Scripps News
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Deliveri - GuruFocus
Alcon stock dips in Zurich as UNITY M launch follows strong Q2 2026 figures - AD HOC NEWS
Alcon Announces Initial Launch of UNITY M Surgical Microscope in US, Japan - marketscreener.com
Alcon Debuts UNITY M Ophthalmic Surgical Microscope in U.S., Japan - Medical Product Outsourcing
Alcon: A Re-Rating In Eyesight - Seeking Alpha
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control - Business Wire
Are Options Traders Betting on a Big Move in Alcon Stock? - TradingView
Changes in working capital of Alcon AG – BX:2U3 - TradingView
Alcon stock holds near 52 week high after Q2 beat - AD HOC NEWS
Alcon (SWX:ALC), What Is Behind The Fresh Attention? - Yahoo Finance
Alcon's Clareon Monofocal IOL Receives EUMDR Certification Through TÜV SÜD - Yahoo Finance
Alcon stock holds steady as drug pricing deal and Q2 reset shape outlook - AD HOC NEWS
Alcon stock edges higher as Q2 2026 impairment and earnings reset the outlook - AD HOC NEWS
Alcon Inc. (ALC) Stock Analysis: A Closer Look At Its 18.37% Potential Upside - DirectorsTalk Interviews
Alcon stock holds steady as latest impairment reshapes its earnings picture - AD HOC NEWS
Alcon stock slips as revenue rises 8.0% in Q2 - AD HOC NEWS
Alcon prices €500M senior notes at 3.875%, due 2033 - Dealroom
Alcon Rolls Out UNITY CS Platform in Canada - Medical Product Outsourcing
Alcon (ALC) Institutional Ownership 2026 $ALC - MarketBeat
Alcon prices €500 million senior notes due 2033 By Investing.com - Investing.com Canada
Alcon stock holds steady as Q2 2026 earnings and guidance frame valuation - AD HOC NEWS
Alcon prices €500 million senior notes due 2033 - Investing.com
SGA Exits Alcon (ALC) as Cataract Demand Slows and Competition Rises - AlphaStreet
Alcon stock edges lower as Swiss shares hover around CHF 58.62 after recent gains - AD HOC NEWS
Alcon’s Q2 2026 Growth Shows UNITY Momentum, but Cataract Softness and Implantables Competition Still Matter - AlphaStreet
Alcon Inc. (ALC): Investor Outlook On Its 15.77% Potential Upside - DirectorsTalk Interviews
Alcon stock holds steady as eye-care demand underpins latest earnings - AD HOC NEWS
Alcon stock trades steadily as analyst targets signal upside - AD HOC NEWS
Alcon stock steady after Q2 2026 sales rise 8 percent - AD HOC NEWS
Alcon stock holds after Q2 sales rose 8 percent - Ad-hoc-news.de
Alcon stock holds in mid-$70 range as Q2 2026 sales rise 8 percent - Ad-hoc-news.de
Alcon stock edges higher after Q2 2026 sales rise and steady mid-$70 trading level - Ad-hoc-news.de
Alcon stock holds steady as analysts point to upside from latest market cap and valuation context. - Ad-hoc-news.de
What Makes Alcon (ALC) a Bullish Bet? - Yahoo Finance
Resilient Alcon stock holds near $73 as Q2 2026 sales and profit outpace growth in eye-care segments - Ad-hoc-news.de
World Council of Optometry, Alcon, and IACLE Partner to Advance Dry Eye Education - InvisionMag.com
Alcon stock trades around $73 as Q2 2026 profit growth and dry eye push shape expectations - AD HOC NEWS
Alcon stock holds in the low $70s as Q2 2026 growth and dry eye push shape the outlook - AD HOC NEWS
Deutsche Bank Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $90 - Moomoo
World Council of Optometry, Alcon and IACLE Partner to Advance Dry Eye Education - VisionMonday.com
Alcon Inc Azioni (ALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):